QSS
CBPO

Quantitative Systematic Strategies’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Quantitative Systematic Strategies’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,052
Closed -$242K – 821
2020
Q4 		$242K Buy
+2,052
New +$238K 0.03% 522

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Quantitative Systematic Strategies's CBPO Position: Q1 2021 in Review

Quantitative Systematic Strategies sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2021, closing a stake of 2,052 shares — an estimated $242K sold.

Quantitative Systematic Strategies first reported a position in CBPO in Q4 2020 and held it in 1 quarter. The position peaked at $242K in Q4 2020. 86 funds tracked by Wall St. Rank hold CBPO as of Q1 2021.

  • Quantitative Systematic Strategies reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 2,052 China Biologic Products Holdings, Inc. shares in Q1 2021, an estimated $242K.
  • Quantitative Systematic Strategies first reported a position in China Biologic Products Holdings, Inc. in Q4 2020 and held it in 1 quarter.
  • Quantitative Systematic Strategies's China Biologic Products Holdings, Inc. position peaked at $242K in Q4 2020.
  • 86 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2021, filed 6 May 2021.